Exposure to thiopurine drugs through breast milk is low based on metabolite concentrations in mother-infant pairs
Version of Record online: 2 MAR 2006
British Journal of Clinical Pharmacology
Volume 62, Issue 4, pages 453–456, October 2006
How to Cite
Gardiner, S. J., Gearry, R. B., Roberts, R. L., Zhang, M., Barclay, M. L. and Begg, E. J. (2006), Exposure to thiopurine drugs through breast milk is low based on metabolite concentrations in mother-infant pairs. British Journal of Clinical Pharmacology, 62: 453–456. doi: 10.1111/j.1365-2125.2006.02639.x
- Issue online: 2 MAR 2006
- Version of Record online: 2 MAR 2006
- Received 24 October 2005Accepted12 December 2005Published OnlineEarly2 March 2006
- 1Anonymous. The Optimal Duration of Exclusive Breastfeeding. Report of an expert consultation (Document WHO/NHD/01.09). Geneva: World Health Organization 28-30 March 2001. Available online at: http://www.who.int/nut/ (last accessed 14 July 2005).
- 3Drugs and Human Lactation, 2nd edn. Amsterdam: Elsevier 1996..
- 9Anonymous. Purinethol. [Prescribing information]. Sellersville, PA: Gate Pharmaceuticals. Available online at http://www.fda.gov/cder/foi/label/2004/09053s024lbl.pdf (last accessed 19 July 2005).
- 13Measurement of thiopurine methyl transferase activity guides dose-initiation and prevents toxicity from azathioprine. NZ Med J 2005; 118: 1210., , , , , , , .
- 14National Center for Health Statistics. Clinical Growth Charts. Available online at http://www.cdc.gov/nchs/data/nhanes/growthcharts/set1clinical/Cj41c017.pdf (last accessed 19 June 2005).